Back to Search Start Over

Engineering cyanobacteria for converting carbon dioxide into isomaltulose.

Authors :
Wu Y
Sun J
Xu X
Mao S
Luan G
Lu X
Source :
Journal of biotechnology [J Biotechnol] 2023 Feb 20; Vol. 364, pp. 1-4. Date of Electronic Publication: 2023 Jan 24.
Publication Year :
2023

Abstract

Isomaltulose is a promising functional sweetener with broad application prospects in the food industry. Currently, isomaltulose is mainly produced through bioconversion processes based on the isomerization of sucrose, the economic feasibility of which is influenced by the cost of sucrose feedstocks, the biocatalyst preparation, and product purification. Cyanobacterial photosynthetic production utilizing solar energy and carbon dioxide represents a promising route for the supply of sugar products, which can promote both carbon reduction and green production. Previously, some cyanobacteria strains have been successfully engineered for synthesis of sucrose, the main feedstock for isomaltulose production. In this work, we introduced different sucrose isomerases into Synechococcus elongatus PCC 7942 and successfully achieved the isomaltulose synthesis and accumulation in the recombinant strains. Combinatory expression of an Escherichia coli sourced sucrose permease CscB with the sucrose isomerases led to efficient secretion of isomaltulose and significantly elevated the final titer. During a 6-day cultivation, 777 mg/L of isomaltulose was produced by the engineered Synechococcus cell factory. This work demonstrated a new route for isomaltulose biosynthesis utilizing carbon dioxide as the substrate, and provided novel understandings for the plasticity of cyanobacterial photosynthetic metabolism network.<br />Competing Interests: Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Yannan Wu, Jiahui Sun, Guodong Luan, Xuefeng Lu has patent pending to CN 202210878243.X. Declaration of Competing Interest The authors have no competing interests to declare.<br /> (Copyright © 2023 Elsevier B.V. All rights reserved.)

Details

Language :
English
ISSN :
1873-4863
Volume :
364
Database :
MEDLINE
Journal :
Journal of biotechnology
Publication Type :
Academic Journal
Accession number :
36702257
Full Text :
https://doi.org/10.1016/j.jbiotec.2023.01.007